Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Humphries

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
British Journal of Pharmacology|July 1, 1985
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptorsR A Brown, J Dixon, J B Farmer, et al.
Cell Metabolism|September 30, 2014
Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levelsNishi Srivastava, Rahul K Kollipara, Dinesh K Singh, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1996
P2T purinoceptor antagonists. A QSAR study of some 2-substituted ATP analoguesN P Tomkinson, D P Marriott, P A Cage, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis modelKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Journal of Medicinal Chemistry|February 2, 1999
Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapyA H Ingall, J Dixon, A Bailey, et al.
Cell Reports|January 26, 2017
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives GlioblastomaDinesh K Singh, Rahul K Kollipara, Vamsidara Vemireddy, et al.
Cancer Discovery|April 30, 2017
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF MelanomaBanu Eskiocak, Elizabeth A McMillan, Saurabh Mendiratta, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
British Journal of Pharmacology|July 1, 1985
Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptorsR A Brown, J Dixon, J B Farmer, et al.
Cell Metabolism|September 30, 2014
Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levelsNishi Srivastava, Rahul K Kollipara, Dinesh K Singh, et al.
The Journal of Pharmacy and Pharmacology|February 1, 1996
P2T purinoceptor antagonists. A QSAR study of some 2-substituted ATP analoguesN P Tomkinson, D P Marriott, P A Cage, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis modelKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Journal of Medicinal Chemistry|February 2, 1999
Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapyA H Ingall, J Dixon, A Bailey, et al.
Cell Reports|January 26, 2017
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives GlioblastomaDinesh K Singh, Rahul K Kollipara, Vamsidara Vemireddy, et al.
Cancer Discovery|April 30, 2017
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF MelanomaBanu Eskiocak, Elizabeth A McMillan, Saurabh Mendiratta, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Pageof 4